Primary and Secondary Infections by Human Parvovirus B19 following Bone Marrow Transplantation: Characterization by PCR and B-Cell Molecular Immunology

References

• Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transpl 1990; 5: 209–226
   PubMed Web of Science ®Google Scholar
• Storek J, Ferrara S, Ku N, Giorgi J V, Champlin R E, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny. Bone Marrow Transpl 1993; 12: 387–398
   PubMed Web of Science ®Google Scholar
• Anderson M J, Lewis E, Kidd I M, Hall S M, Cohen B J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Camb) 1984; 93: 85–93
   PubMedGoogle Scholar
• Bartolomei Corsi O, Azzi A, Morfini M, Fanci R, Rossi-Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165–170
   PubMedGoogle Scholar
• Young N, Harrison M, Moore J, Mortimer P, Humphries R K. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest 1984; 74: 2024–2032
   PubMed Web of Science ®Google Scholar
• Pattison J R, Jones S E, Hodgson J, Davis L R, White J M, Stroud C E, Murtaza L. Parvoviral infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981; 1: 664–665
   PubMed Web of Science ®Google Scholar
• Faden H, Gary J G.W., Anderson L J. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992; 15: 595–597
   PubMedGoogle Scholar
• Murray J C, Gresik M V, Leger F, McClain K L. B19 parvovirus-induced anemia in a normal child. Initial bone marrow erythroid hyperplasia and response to intravenous immunoglobulin. Am J Pediatr Hematol Oncol 1993; 15: 420–423
   PubMedGoogle Scholar
• Kurtzman G J, Ozawa K, Cohen B, Hanson G, Oseas R, Young N S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287–294
   PubMed Web of Science ®Google Scholar
• Frickhofen N, Abkowitz J L, Safford M, Berry J M, Anturez-de-Mayolo J, Astrow A, Cohen R, Haperin I, King L, Mintzer D. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926–933
   PubMed Web of Science ®Google Scholar
• Anderson M J, Higgins P G, Davis L R, Willman J S, Jones S E, Kidd I M, Pattison J R, Tyrrell D A. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257–265
   PubMed Web of Science ®Google Scholar
• Weiland H T, Salimans M MM, Fibbe W E, Kluin P M, Cohen B J. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Br J Haematol 1989; 79: 300
   Google Scholar
• Pillay D, Patou G, Griffiths P, Rees L. Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 1991; 10: 623–624
   PubMed Web of Science ®Google Scholar
• Bremner J AG, Beard S, Cohen B J, Alimenti A, Cantiniaux B, Levy J. Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS 1993; 7: 1131–1132
   PubMedGoogle Scholar
• Cassinotti P, Schultze D, Wieczorek K, Schönenberger R, Siegl G. Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for preexisting anti-B19 antibody: how reliable are serological results?. Clin Diagnos Virol 1994; 2: 87–94
   PubMedGoogle Scholar
• Gundestrup M, Yun Z-B, Hornsleth A, Jacobsen N. High incidence of posttransplant parvovirus B19 infection in a consecutive series of 184 bone marrow allograft recipients. A probable cause of post-transplant pancytopenia. Experimental Hematology, P J Quesenberry. Springer International, ParmaItaly 1991; 571
   Google Scholar
• Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young N S. Parvovirus B19 infection and bone marrow transplantation. Ann Hematol 1992; 64: 121–124
   Google Scholar
• Söderlund M, Brown C S, Cohen B J, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995; 171: 710–713
   PubMed Web of Science ®Google Scholar
• Söderlund M, Brown C S, Spaan W JM, Hedman L, Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995; 172: 1431–1436
   PubMed Web of Science ®Google Scholar
• Franssila R, Söderlund M, Brown C, Spaan W, Seppälä I, Hedman K. IgG subclass response to human parvovirus B19 infection. Clin Diagnos Virol 1996; 6: 41–49
   PubMedGoogle Scholar
• Söderlund M, Brown K E, Meurman O, Hedman K. Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol 1992; 30: 305–311
   PubMedGoogle Scholar
• Brown C S, van Lent J WM, Vlak J M, Spaan W JM. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol 1991; 65: 2702–2706
   PubMed Web of Science ®Google Scholar
• Cohen B J, Mortimer P P, Pereira M S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Camb) 1983; 91: 113–130
   PubMedGoogle Scholar
• Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993; 4: 123–129
   Google Scholar
• Shade R O, Blundell M C, Cotmore S F, Tattersall P, Astell C R. Nucleotide sequence and genome organization of human parvovirus B19 isolated from a child during aplastic crisis. J Virol 1986; 58: 921–936
   PubMed Web of Science ®Google Scholar
• Azzi A, Fanci R, Ciappi S, Zakrzewska K, Bosi A. Human parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 1993; 44: 207–209
   PubMedGoogle Scholar
• Erdman D D, Usher M J, Tsou C, Caul E O, Gary G W, Kajigaya S, Young N S, Anderson L J. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991; 35: 110–115
   PubMedGoogle Scholar
• Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995; 172: 1360–1363
   PubMed Web of Science ®Google Scholar
• Wahren B, Gahrton G, Linde A, Ljungman P, Lönnqvist B, Ringden O, Sundqvist V A. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150: 358–365
   PubMedGoogle Scholar
• Wimperis J Z, Brenner M K, Prentice H G, Reittie J E, Karayiannis P, Griffiths P D, Hoffbrand A V. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; i: 339–343
   Google Scholar
• Adler S P, Manganello A-MA, Koch W C, Hempffing S H, Best A M. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 1993; 168: 361–368
   PubMedGoogle Scholar
• Gray J, Cohen B, Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Meth 1993; 44: 11–24
   PubMedGoogle Scholar
• Lutz E, Ward K N, Szydlo R, Goldman J M. Cytomegalo-virus antibody avidity in allogeneic bone marrow recipients: Evidence for primary or secondary humoral responses depending on donor immune status. J Med Virol 1966; 49: 61–65
   Google Scholar
• Thomas H IJ, Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 1988; 101: 591–598
   PubMedGoogle Scholar
• Enders G, Knotek F. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 1989; 17: 218–226
   PubMedGoogle Scholar
• Hedman K, Rousseau S A. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 1989; 27: 288–292
   PubMed Web of Science ®Google Scholar
• Aalberse R C, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. Prolonged immunization results in an IgG4-restricted response. J Immun 1983; 130: 722–726
   PubMed Web of Science ®Google Scholar